KEGG pathway enrichment analysis of lactoferrin and Coenzyme Q10 in sarcopenia. by Wenbin Wu (292223)

Subjects:

Effects of lactoferrin and Coenzyme Q10 on skeletal muscle of mice. by Wenbin Wu (292223)

Subjects:

Each group’s performance on behavioral tests. by Wenbin Wu (292223)

Subjects:

Parameters for the treadmill during the testing phase. by Wenbin Wu (292223)

Subjects:

Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs. by Wenbin Wu (292223)

Subjects:

HE staining of the gastrocnemius muscle. by Wenbin Wu (292223)

Subjects:

qPCR verified the expression changes of GO and KEGG pathway enriched sarcopenia related DEGs. by Wenbin Wu (292223)

Subjects:

Flowchart of included and excluded patients. by P.G.J. ter Horst (21743830)

Subjects:

Prevalence of low semen quality including 95% confidence interval (CI) for medication at the ATC 3 level. by P.G.J. ter Horst (21743830)

Subjects:

S1 Data - Medication, age and abstinence days associated with low semen quality: A cross-sectional study in more than 7000 men visiting the centre for reproductive medicine by P.G.J. ter Horst (21743830)

Subjects:

Univariable and multivariable analyses (age-adjusted), concerning a selection of medicaments p < 0.1 and n ≥ 10. by P.G.J. ter Horst (21743830)

Subjects:

Prevalence of low semen quality including 95% confidence interval (CI) for medication at the ATC 7 level. by P.G.J. ter Horst (21743830)

Subjects:

Characteristics of the study group. by P.G.J. ter Horst (21743830)

Subjects:

Univariable and multivariable analyses (age- and abstinence days-adjusted), concerning medicament(s) use and Low Semen Quality (LSQ). by P.G.J. ter Horst (21743830)

Subjects:

A. Proportion of men with Low Semen Quality (LSQ) including 95% confidence interval (CI) versus prevalence, overall and for men on medication(s) (M); B: Point estimates with 95% CI... by P.G.J. ter Horst (21743830)

Subjects:

Prevalence of low semen quality including 95% confidence interval (CI) for medication at the ATC 5 level. by P.G.J. ter Horst (21743830)

Subjects:

Univariable and multivariable analyses (age- and abstinence days-adjusted), concerning a selection of medicaments with n ≥ 10 medicament users and p < 0.1 by univariate analysis.... by P.G.J. ter Horst (21743830)

Subjects:

The speed diagram. by Yifei Li (198040)

Subjects:

Factors of orthogonal experiment. by Yifei Li (198040)

Subjects:

Analysis of variance in orthogonal test. by Yifei Li (198040)

Subjects: